Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm

Human Genetics

Volumn 110, Issue 1, 2002, Pages 89-94

  Ito, Teruhiko ^a   Yasue, Hirofumi ^b   Yoshimura, Michihiro ^a   Nakamura, Shota ^a   Nakayama, Masafumi ^a   Shimasaki, Yukio ^a   Harada, Eisaku ^a   Mizuno, Yuji ^b   Kawano, Hiroaki ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Kumamoto Aging Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ARGININE; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; CHOLESTEROL; GLUTAMINE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOSORBIDE DINITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY SPASM; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; HYPOTHESIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OXIDATIVE STRESS; PATHOGENESIS; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARGININE; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; CORONARY VASOSPASM; DIABETES COMPLICATIONS; ESTERASES; FEMALE; GENOTYPE; GLUTAMINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SMOKING; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0036461239     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-001-0654-6     Document Type: Article

References (52)

1. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P (1995) The effects of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332:488-493
2. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, Du BL (1998a) Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 18:1617-1624
3. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998b) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1581-1590
4. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M (2000) Human serum paraoxonases(PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions. PON1 esterase and peroxidase-like activities. Circulation 101: 2510-2517
5. Bauters C, Amant C, Boulier A, Cabrol P, McFadden E, Duriez P, Bertrand ME, Amouyel P (2000) Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. Circulation 101:740-743
6. Bernhardt R, Feng Z, Deng Y, Wanz Z, Cheng S, Cremer P, Thiery J, Seidel D, Schettler G (1987) Coronary risk factors in China: A comparative study of middle-aged workers in China and Germany. In: Stehle G, Bernardt R (eds) Coronary Risk Factors in Japan and China. Springer, Berlin Heidelberg New York, pp 22-53
7. Bertrand ME, LaBlance JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM (1982) Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 65:1299-1306
8. Blatter-Garin MC, James RW, Dussoix P, Blanche H, Passsa P, Froguel P, Ruiz J (1998) Paraoxonase polymorphism MetLeu54 is associated with modified serum concentrations of the enzyme. J Clin Invest 99:62-66
9. Buege JA, Aust SD (1987) Microsomal lipid peroxidation. Methods Enzymol 52:302-310
10. Caralis DG, Deligonul U, Kern MJ, Cohen JD (1992) Smoking is a risk factor for coronary spasm in young women. Circulation 85:905-909
11. Durrington PN, Mackness MI (2000) Still life in oxidation hypothesis of atherogenesis. Lancet 356:165
12. Herrmann SM, Blanc H, Poirier O, Arveiler D, Luc G, Evans A, Marques-Vidal P, Bard JM, Canbien F (1996) The Gln/Arg polymorphism of human paraoxonase (PON192) is not related to myocardial infarction in the ECTIM Study. Atherosclerosis 126:299-303
13. Hillis LD, Braunwald E (1978) Coronary-artery spasm. N Engl J Med 299:695-702
14. Humbert R, Adler DA, Distecke CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Gen 3:73-76
15. James RW, Leviev I, Righetti A (2000a) Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 101:2252-2257
16. James RW, Leviev I, Ruiz J, Passa P, Froguel P, Blatter-Garin MC (2000b) Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 49:1390-1393
17. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H (1996a) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94:266-272
18. Kugiyama K, Yasue H, Ohgushi M, Motoyama T, Kawano H, Inobe Y, Hirashima O, Sugiyama S (1996b) Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 28:1161-1167
19. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, Kawano H, Miyao Y, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Yasue H (1998) Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 32:103-109
20. Mackness MI, Arrol S, Abbot CA, Durrington PN (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104:129-135
21. Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ, Navab M, Shih DM, Fonarow GC (1998) Paraoxonase and coronary heart disease. Curr Opin Lipidol9:319-324
22. Mackness B, Durrington PN, Mackness MI (1999) Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation. Lancet 353:468-469
23. Mackness MI, Durrington PN, Mackness B (2000) How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11:383-388
24. Maseri A, Davies G, Hackett D, Kaski JC (1990) Coronary artery spasm and vasoconstriction: The case for a distinction. Circulation 81:1983-1991
25. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H (1996) Vitamin E deficiency in variant angina. Circulation 94:14-18
26. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M, Ogawa H, Yasue H (1997) Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: Effect of vitamin C. Am J Physiol 273:H1644-H1650
27. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, Yasue H (1998) Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 32:1672-1679
28. -786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870
29. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizaka H, Sumida H, Fujii H, Matsunaga T, Tsunoda R (1996) Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 27:45-52
30. Ombres D, Pannitteri G, Montali A, Candeloro A, Seccareccia F, Campagna F, Cantini R, Campa PP, Ricci G, Arca M (1998) The Gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler Thromb Vasc Biol 18:1611-1616
31. Paolisso G, Manzella D, Tagliamonte MR, Barbieri M, Marfella R, Zito G, Bonafe M, Giugliano D, Franceschi C, Varricchio M (2001) The BB-paraoxonase genotype is associated with impaired brachial reactivity after acute hypertriglyceridemia in healthy subjects. J Clin Endocrinol Metab 86:1078-1082
32. Ruiz J, Blanche H, James RW, Garin MB, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P (1995) Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346:869-872
33. Serrato M, Marian AJ (1995) A variant of human paraoxonase/arylesterase (HUPONA) gene is a risk factor for coronary artery disease. J Clin Invest 96:3005-3008
34. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287
35. Simon BC, Cunningham LD, Cohen RA (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86:75-79
36. Stafforini DM, Sotoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, Imaizumi T, Takamatsu S, Zimmerman GA, McIntyre TM, Gray PW, Prescott SM (1996) Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 97:2784-2791
37. Stehel G, Hinohara S, Gross K, Tamati H, Kanemoto W, Fehringer M, Takahashi T, Goto Y, Schettler G (1998) Influence of alcohol consumption, smoking, and exercise habits on blood lipoprotein concentrations in 9256 healthy Japanese adults. In: Schettler G (ed) Endemic Disease and Risk Factors for Atherosclerosis in the Far East. Springer, Berlin Heidelberg New York, pp 13-25
38. Suehiro T, Nakauchi Y, Yamamoto M, Arii K, Itoh H, Hamashige N, Hashimoto K (1996) Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int J Cardiol 57:69-73
39. Sugiishi M, Takatsu F (1993) Cigarette smoking is a major risk factor for coronary spasm. Circulation 87:76-79
40. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Y, Mizuno Y, Sakamoto T, Yasue H (2000) Comparison of the risk factors for coronary artery spasm with those for organic stenosis in Japanese population: Role of cigarette smoking. Int J Cardiol 72:121-126
41. Van Lenten BJ, Hama SY, Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M (1995) Anti-inflammatory HDL becames pro-inflammatory during the acute phase response. J Clin Invest 96:2758-2767
42. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, La Du BN, Fogelman AM, Berliner JA (1995) Effect of platelet-activating factor-acetylhydrolase on the formation and action of minimally oxidised low-density lipoprotein. J Clin Invest 95:774-782
43. 192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese. Hum Genet 101:67-68
44. Yasue H (1980) Pathophysiology and treatment of coronary arterial spasm. Chest 78 (Suppl):216-223
45. Yasue H, Kugiyama K (1990) Coronary artery spasm: Japanese view. Coronary Artery Dis 1:668-673
46. Yasue H, Omote S, Takizawa A, Nagao M (1983) Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res 52 (Suppl I):147-152
47. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H (1990) Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 81:482-490
48. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103:65-69
49. -786→C and missense Glu298Asp variants. J Invest Med 48:367-374
50. Zama T, Murata M, Matsubara Y, Kawano K, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y (1997) A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 17:3565-3569
51. Zeiher AM, Drexler H, Wollschlanger H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391-401
52. Zeiher AM, Schachinger V, Minners J (1995) Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92:1094-1100